Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Published in: Clinical & Experimental Metastasis 6/2005

01-11-2005

Focal Adhesion Kinase is Activated in Invading Fibrosarcoma Cells and Regulates Metastasis

Authors: Masuo Hanada, Kazuhiro Tanaka, Yoshihiro Matsumoto, Fumihiko Nakatani, Riku Sakimura, Tomoya Matsunobu, Xu Li, Takamitsu Okada, Tomoyuki Nakamura, Minoru Takasaki, Yukihide Iwamoto

Published in: Clinical & Experimental Metastasis | Issue 6/2005

Login to get access
Metadata
Title
Focal Adhesion Kinase is Activated in Invading Fibrosarcoma Cells and Regulates Metastasis
Authors
Masuo Hanada
Kazuhiro Tanaka
Yoshihiro Matsumoto
Fumihiko Nakatani
Riku Sakimura
Tomoya Matsunobu
Xu Li
Takamitsu Okada
Tomoyuki Nakamura
Minoru Takasaki
Yukihide Iwamoto
Publication date
01-11-2005
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 6/2005
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-005-3733-6

Other articles of this Issue 6/2005

Clinical & Experimental Metastasis 6/2005 Go to the issue

OriginalPaper

Plasma Gelatinase Levels in Patients with Primary Breast Cancer in Relation to Axillary Lymph Node Status, Her2/neu Expression and other Clinicopathological Variables

Technical Communication

Mouse Colon Carcinoma Cells Established for High Incidence of Experimental Hepatic Metastasis Exhibit Accelerated and Anchorage-Independent Growth

OriginalPaper

Restoration of Smad4 in BxPC3 Pancreatic Cancer Cells Attenuates Proliferation without Altering Angiogenesis

OriginalPaper

KiSS-1 Expression in Human Breast Cancer

OriginalPaper

MUC1 Mediates Transendothelial Migration in vitro by Ligating Endothelial Cell ICAM-1

OriginalPaper

ICAM-1 Mediated Peritoneal Carcinomatosis, A Target for Therapeutic Intervention
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits